Urtoxazumab
Urtoxazumab Basic information
- Product Name:
- Urtoxazumab
- Synonyms:
-
- Urtoxazumab
- Research Grade Urtoxazumab (DXX00501)
- Research Grade Urtoxazumab
- CAS:
- 502496-16-4
- MW:
- 0
- Mol File:
- Mol File
More
Less
Urtoxazumab Usage And Synthesis
Uses
Urtoxazumab (TMA-15) is a humanizedized monoclonal antibody against Shiga toxin (Stx) 2[1].
in vivo
Urtoxazumab (TMA-15) (0.25-2.5 mg/kg; i.v.; once) ameliorates the lethal challenge in a time- and dose- dependent manner in B2F1-infected mice[1].
| Animal Model: | 5-week-old male DBA/2J mice, STEC B2F1-infection model[1] |
| Dosage: | 0.25, 0.5, 1.0, 2.0 and 2.5 mg/kg |
| Administration: | Intravenous administration, 1 h before and 12, 24, and 48 h after infection |
| Result: | Pretreatment completely protected the infected mice from death, the efficacy of the low dose (0.25 mg/kg) was partial when administered at 12 and 24 h after infection, but the efficacy of the high dose (2.5 mg/kg) was still complete. Prevented death from B2F1 infection in all 20 animals at 1.0 and 2.0 mg/kg 24 h after infection. |
References
[1] Yamagami S, et al. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J Infect Dis. 2001 Sep 15;184(6):738-42. DOI:10.1086/323082
UrtoxazumabSupplier
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
Wuhan Jingkangen Biomedical Technology Co., Ltd
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
Shanghai Yifei Biotechnology Co. , Ltd.
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
Changsha Fuzhen Biotechnology Co.，LTD
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com